Geovax partners with abl to advance cgmp production of vaccine candidates

Atlanta, ga, may 31, 2023 (globe newswire) -- via newmediawire – geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced it has executed a master services agreement (msa) with advanced bioscience laboratories, inc. (abl) to support current good manufacturing practices (cgmp) production of the company's vaccine candidates, including geo-mva and geo-cm04s1.
GOVX Ratings Summary
GOVX Quant Ranking